Identifying factors associated with hypoglycemia-related hospitalizations among elderly patients with T2DM in the US: A novel approach using influential variable analysis

Current Medical Research and Opinion

Volumn 30, Issue 9, 2014, Pages 1787-1793

  Fu, Haoda ^a   Xie, Wenting ^a   Curtis, Brad ^a   Schuster, Dara ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Boosted regression tree model; Elderly; Hospitalization; Hypoglycemia; Insulin; Sulfonylurea

Indexed keywords

ANTIDIABETIC AGENT;

AGED; CHEMICALLY INDUCED; COHORT ANALYSIS; COMORBIDITY; COMPLICATION; DIABETES MELLITUS, TYPE 2; EVALUATION STUDY; FEMALE; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INCIDENCE; MALE; RETROSPECTIVE STUDY; RISK; RISK FACTOR; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84906826986     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2014.922944     Document Type: Article

References (33)

1. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010;340:b4909
2. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59
3. Miller ME, Bonds DE, Gerstein HC, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010;340:b5444
4. Curkendall SM, Natoli JL, Alexander CM, et al. Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract 2009;15:302-12
5. Turchin A, Matheny ME, Shubina M, et al. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 2009;32:1153-7
6. Rossetti P, Porcellati F, Bolli GB, et al. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs. Diabetes Care 2008;31(Suppl 2):S113-20
7. Sinclair AJ, Paolisso G, Castro M, et al. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011;37(Suppl 3):S27-38
8. Sinclair AJ. Diabetes in old age-changing concepts in the secondary care arena. J R Coll Physicians (Lond) 2000;34:240-4
9. Sinclair AJ. Special considerations in older adults with diabetes: meeting the challenge. Diabetes Spectrum 2006;19:229-33
10. Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010;363:1410-18
11. Bloomgarden ZT, Einhorn D. Hypoglycemia in type 2 diabetes: current controversies and changing practices. Front Endocrinol (Lausanne) 2012;3:66
12. Yaffe K, Falvey CM, Hamilton N, et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013;173:1300-6
13. Johnson ES, Koepsell TD, Reiber G, et al. Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol 2002;55:253-9
14. Bramlage P, Gitt AK, Binz C, et al. Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia. Cardiovasc Diabetol 2012;11:122
15. Moen MF, Zhan M, Hsu VD, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1121-7
16. Ginde AA, Blanc PG, Lieberman RM, et al. Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits. BMC Endocr Disord 2008;8:4
17. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning, 2nd edn. New York: Springer, 2009
18. Ridgeway G. Generalized boosted regression models: a guide to the gbm package. 2013. Available at: http://cran.r-project.org/web/packages/gbm/gbm.pdf [Last accessed 30 December 2013]
19. Freund Y, Schapire RE. Experiment with a new boosting algorithm. In: Machine Learning: Proceedings of the Thirteenth International Conference. Morgan Kaufmann Publishers, 1996;148-56
20. Deconick E, Zhang MH, Petitet F, et al. Boosted regression trees, multivariate adaptive regression splines and their two-step combinations with multiple linear regression or partial least squares to predict blood-brain barrier passage: a case study. Anal Chim Acta 2008;609:13-23
21. Elith J, Leathwick JR, Hastie T. A working guide to boosted regression trees. J Anim Ecol 2008;77:802-13
22. Mjolsness E, DeCoste D. Machine learning for science: state of the art and future prospects. Science 2001;293:2051-5
23. American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care 2013;36:1033-46
24. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care 2012;35:2650-64
25. Punthakee Z, Miller ME, Launer LJ, et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012;35:787-93
26. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301:1565-72
27. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012;35(Suppl 1):S11-63
28. Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168:1890-6
29. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
30. Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006;355:2427-43
31. Thulé PM, Umpierrez G. Sulfonylureas: a new look at old therapy. Curr Diab Rep 2014;14:473.
32. Krepinsky J, Ingram AJ, Clase CM. Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease. Am J Kidney Dis 2000;35:500-33
33. Williams SA, Shi L, Brenneman SK, et al. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients. J Diabetes Complications 2012;26:399-406